BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 28823098)

  • 21. Immunohistochemical detection of nestin in pediatric brain tumors.
    Almqvist PM; Mah R; Lendahl U; Jacobsson B; Hendson G
    J Histochem Cytochem; 2002 Feb; 50(2):147-58. PubMed ID: 11799134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III.
    Varughese RK; Lind-Landström T; Habberstad AH; Salvesen Ø; Haug CS; Sundstrøm S; Torp SH
    J Clin Pathol; 2016 Jan; 69(1):26-34. PubMed ID: 26188054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An immunohistochemical and ultrastructural study of 243 gliomas with reference to the prognosis].
    Bian XW
    Zhonghua Bing Li Xue Za Zhi; 1992 Jun; 21(3):171-3. PubMed ID: 1335846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid immunohistochemical detection of tumor cells in gastric carcinoma.
    Mönig SP; Luebke T; Soheili A; Landsberg S; Dienes HP; Hölscher AH; Baldus SE
    Oncol Rep; 2006 Nov; 16(5):1143-7. PubMed ID: 17016606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reproducibility of SOX-11 detection in decalcified bone marrow tissue in mantle cell lymphoma patients.
    Righi S; Pileri S; Agostinelli C; Bacci F; Spagnolo S; Sabattini E
    Hum Pathol; 2017 Jan; 59():94-101. PubMed ID: 27720733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of PCNA, Ki67, AgNOR and p53 expression in brain glial tumors].
    Berny W; Weiser A; Markowska-Woyciechowska A; Jarmundowicz W; Zub W; Załuski R
    Neurol Neurochir Pol; 2004; 38(6):457-63. PubMed ID: 15654669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytoplasmic localization of wild-type p53 in glioblastomas correlates with expression of vimentin and glial fibrillary acidic protein.
    Sembritzki O; Hagel C; Lamszus K; Deppert W; Bohn W
    Neuro Oncol; 2002 Jul; 4(3):171-8. PubMed ID: 12084347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glial fibrillary acidic protein expression in pleomorphic adenoma, chordoma, and astrocytoma. A comparison of three antibodies.
    Wittchow R; Landas SK
    Arch Pathol Lab Med; 1991 Oct; 115(10):1030-3. PubMed ID: 1654872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
    Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
    Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new rapid immunohistochemical staining technique using the EnVision antibody complex.
    Kämmerer U; Kapp M; Gassel AM; Richter T; Tank C; Dietl J; Ruck P
    J Histochem Cytochem; 2001 May; 49(5):623-30. PubMed ID: 11304800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of malignant features in oligodendroglial tumors.
    Saito A; Nakazato Y
    Clin Neuropathol; 1999; 18(2):61-73. PubMed ID: 10192700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic immunohistochemical profiling of 378 brain tumors with 37 antibodies using tissue microarray technology.
    Ikota H; Kinjo S; Yokoo H; Nakazato Y
    Acta Neuropathol; 2006 May; 111(5):475-82. PubMed ID: 16598485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IDH1-Mutation in Diffuse Gliomas in Persons Age 55 Years and Over.
    Robinson C; Kleinschmidt-DeMasters BK
    J Neuropathol Exp Neurol; 2017 Feb; 76(2):151-154. PubMed ID: 28110298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of IDH1 mutation in human gliomas: comparison of immunohistochemistry and sequencing.
    Takano S; Tian W; Matsuda M; Yamamoto T; Ishikawa E; Kaneko MK; Yamazaki K; Kato Y; Matsumura A
    Brain Tumor Pathol; 2011 Apr; 28(2):115-23. PubMed ID: 21344322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low grade diffuse gliomas: shared cellular composition and morphometric differences.
    Kinjo S; Hirato J; Nakazato Y
    Neuropathology; 2008 Oct; 28(5):455-65. PubMed ID: 18282166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemistry in the diagnosis of neoplasms of the central nervous system.
    Morrison CD; Prayson RA
    Semin Diagn Pathol; 2000 Aug; 17(3):204-15. PubMed ID: 10968706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of gliomas by morphological and immunocytochemical analysis in cell cultures.
    Fazekas I; Kerekes E; Hegedús B; Nyáry I
    Ideggyogy Sz; 2002 May; 55(5-6):173-9. PubMed ID: 12122877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of an ultrasound-emitting device for performing rapid immunostaining procedures.
    Hatta H; Tsuneyama K; Kondo T; Takano Y
    J Histochem Cytochem; 2010 May; 58(5):421-8. PubMed ID: 20124095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The contribution of bifunctional SkipDewax pretreatment solution, rabbit monoclonal antibodies, and polymer detection systems in immunohistochemistry.
    Wong SC; Chan JK; Lo ES; Chan AK; Wong MC; Chan CM; Lam MY; Chan AT
    Arch Pathol Lab Med; 2007 Jul; 131(7):1047-55. PubMed ID: 17616990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The determination of glial fibrillary acidic protein for the diagnosis and histogenetic study of central nervous system tumors: a study of 152 cases.
    Hamaya K; Doi K; Tanaka T; Nishimoto A
    Acta Med Okayama; 1985 Dec; 39(6):453-62. PubMed ID: 4091041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.